An interventional study of Bedroom air filtered by an air filtration device to remove airborne pollutants in Asthma in Children, sponsored by Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine. Status unknown at 1 site in China. Open to participants aged 5 Years to 14 Years. Per ClinicalTrials.gov, last updated 2020-03-23.
Sponsored by Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine · Not applicable, Interventional, and Prevention
This study uses a crossover study design to examine the impact of a two-week bedroom based indoor air filtration on the concentration of indoor airborne pollutants, personal exposure to airborne pollutants and health indicators among asthmatic children living in Shanghai, China
This study recruited asthmatic children aged 5 to 14 who were living in Shanghai, China. Every study subject had the air in their bedroom processed by an air filtration device (with a pre-filter, a HEPA filter and an active carbon filter) for two weeks (active comparator arm), processed by a placebo air filtration device (which did not possess the HEPA filter and active carbon filters) for two weeks (placebo arm), and underwent a two-week washout period (no use of air filtration device) between the two intervention periods. The doors and windows of the bedroom were instructed to be kept closed during the intervention periods. The sequence of being in the active comparator arm and the placebo arm was randomized for each subject. The subject, their guardian and researchers who have direct interaction with the study subjects do not know this sequence until after the end of the study.
The study protocol was approved by IRB at Shanghai First People's Hospital, Duke University and University of Wisconsin at Madison. A sample size of 40 was calculated using fractional exhaled nitric oxide (FeNO) as the primary outcome where statistical significance was set at 0.05, power at 90%, and between-subject variance and covariance were estimated from existing literature. Four additional subjects were added to the estimated sample size of 40 to account for potential dropouts. Subjects were recruited from patients who attended the outpatient clinic of the Pediatrics Department of Shanghai First People's Hospital (south section) by Dr. Zhen Li and Dr. Junfeng Zhang's team. Assent was obtained from all study subjects and written informed consent was obtained from their guardians.
During the study, Dr. Michael Bergin's team and Dr. Yinping Zhang's team installed the air filtration devices in the subject's bedroom and measured the indoor concentration, outdoor concentration and personal exposure to airborne pollutants including PM2.5, ozone and volatile organic compounds. Dr. James Schauer's team analyzed the physical, chemical and bioactivity of the airborne particles collected and had no direct contact with the study subjects.
Each subject attended 5 clinical visits at the Shanghai First People's Hospital (South Section) accompanied by their guardian where clinical assessment (of lung function, fractional exhaled nitric oxide, asthma symptom blood draw) was performed by Drs. Zhen Li and Feng Li's team, and the collection of biological media (urine, saliva and nasal fluid) was conducted by Dr. Junfeng (Jim) Zhang's team. In addition, subjects were instructed to measure the peak expiratory flow (PEF) at 7am and 9pm daily and recorded their asthma symptoms at home with the assistance from their guardian(s). The biological media (urine, saliva and nasal fluid) collected was subsequently analyzed by Dr. Junfeng (Jim) Zhang's team for health indicators.
Each subject had access to the result of clinical assessment and health indicator in biological media, as well as free consultation from the medical teams of Drs. Zhen Li and Feng Li. Every subject was remunerated with 1000RMB (equivalent to 152 US dollars) and given a peak expiratory flow meter (worth less than 10 US dollars). All information collected from study subjects were recorded under their subject ID number and kept confidential. Only de-identified data was shared between collaborating investigators. Statistical analysis including mixed-effects models will be conducted on the data collected.
4,010 studies on the registry are indexed under Asthma; 514 are open to participants now.
This study's enrollment of 43 is below the median of 83 across 2,814 interventional studies indexed under Asthma.
Browse Asthma studies →Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine is the lead sponsor of 182 studies on the registry; 108 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
An eligible child is defined as:
An eligible household is defined as:
Exclusion Criteria:
The air in the bedroom of study subjects in the active comparator arm was filtered by an air filtration device which processed air through a pre-filter, a high efficiency particular air (HEPA) filter and an active carbon filter. The duration of being in the active comparator arm was 2 weeks.
Device: Bedroom air filtered by an air filtration device to remove airborne pollutants
The air in the bedroom of subjects in the placebo arm was filtered by a placebo air filtration device that looked identical to the real air filtration device but did not possess the HEPA filter and the active carbon filter. The duration of being in the placebo arm was 2 weeks.
Device: Bedroom air filtered by an air filtration device to remove airborne pollutants
The air in the bedroom of study subjects in the active comparator arm was processed by an air filtration device which pulled air through a pre-filter, a high efficiency particular air (HEPA) filter and an active carbon filter continuously. The air in the bedroom of subjects in the placebo arm was processed by a placebo air filtration device that looked identical to the real air filtration device but did not possess the HEPA filter and the active carbon filter. Each subject was assigned to the active comparator arm and the placebo arm in a randomized order with a two-week washout period scheduled in-between. The subjects, their guardians and the study staff that assessed the health indicators of the subjects were blinded to this order till the end of the study.
Fractional exhaled nitric oxide (FeNO)
Fractional exhaled nitric oxide (FeNO) was measured using the NIOX machine
Time frame: Change of FeNO after the end of the two-week intervention compared to the start of the two-week intervention period
Asthma symptoms
Asthma symptom was evaluated by the Asthma Control Test (ACT) questionnaire
Time frame: Within 24 hours before the start of intervention and within 24 hours after the end of intervention
Peak expiratory flow (PEF)
The maximum speed of exhalation (PEF) was measured by a handheld PEF meter (Koka Peak Expiratory Flow Meter)
Time frame: Measured at 7am and 9pm daily during the two-week intervention
Lung function
Lung function was assessed by spirometry (Jaeger MasterScreen™ PFT system) and impulse oscillometry (Jaeger MasterScreenTM IOS).
Time frame: Within 24 hours before the start of intervention and within 24 hours after the end of intervention
Malondialdehyde (MDA) concentration in urine
Malondialdehyde (MDA) concentration in urine was measured using the thiobarbituric acid derivatization method and high-performance liquid chromatography (HPLC)
Time frame: Within 24 hours before the start of intervention and within 24 hours after the end of intervention
8-OHdG concentration in urine
Concentration of 8-hydroxydeoxyguanosine (8-OHdG) in urine was measured by solid phase extraction and liquid chromatography-mass spectrometry (LC-MS)
Time frame: Within 24 hours before the start of intervention and within 24 hours after the end of intervention
Malondialdehyde (MDA) concentration in nasal fluid
Malondialdehyde (MDA) concentration in nasal fluid was measured using the thiobarbituric acid derivatization method and high-performance liquid chromatography (HPLC)
Time frame: Within 24 hours before the start of intervention and within 24 hours after the end of intervention
Malondialdehyde (MDA) concentration in saliva
Malondialdehyde (MDA) concentration in saliva was measured using the thiobarbituric acid derivatization method and high-performance liquid chromatography (HPLC)
Time frame: Within 24 hours before the start of intervention and within 24 hours after the end of intervention
Interleukin-6 level in saliva
The concentration of interleukin-6 in saliva was measured by enzyme-linked immunosorbent assay (ELISA)
Time frame: Within 24 hours before the start of intervention and within 24 hours after the end of intervention
Eosinophil cationic protein concentration in saliva
The concentration of eosinophil cationic protein in saliva was measured by enzyme-linked immunosorbent assay (ELISA)
Time frame: Within 24 hours before the start of intervention and within 24 hours after the end of intervention
Blood eosinophil
Blood eosinophil was assessed using the blood routine test
Time frame: Only once at the time of enrollment into the study
Allergen profile
The IgE antibody for 19 allergens were assessed using serum samples from study subjects.
Time frame: Only once at the time of enrollment into the study
Chemical exposure
Personal exposure to chemicals including flame retardant and organophosphates was assessed using silicone wristbands that were worn on the wrist of study subjects for 1 week
Time frame: During 1 week of the study
Plan to share: Undecided
This study is status unknown, as verified in Mar 2020. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine →